Stacks and blends

MOTS-c + SS-31

the mitochondrial stack

No trial of the combination

What is in it

The components come in separate vials and are taken alongside each other:

ComponentTaken alone: typical doseHow oftenStatus
MOTS-c5–10 mg2–3 times weeklyNot approved
SS-3140 mgDailyFDA-approved

Doses reported online

No dose has been established for this combination, because it has never been through a human trial. The figures below are what named websites publish, collected in October 2026. Several of those sites sell peptides or earn commission from sellers. We report them so you can see what is being said and where it comes from. This is not a recommendation.

The sources disagree by five to ten times on both peptides, and one of them does not take the two together at all, alternating them through the year. A third source we read, a seller, withdrew its earlier protocol and now says no schedule has been established.

Hunter’s Health Hacks (Hunter Williams)Coach’s newsletter describing his own use. No medical credentials stated.
Each doseMOTS-c 1 mg. SS-31 1–2 mg for healthy people, 2–5 mg and upward for illness.
How oftenMOTS-c once a day, 5 days on and 2 off. SS-31 once a day. He alternates the two instead of combining them.
Weekly totalMOTS-c 5 mg. SS-31 7–14 mg at the lower tier.
LengthMOTS-c 8–12 weeks.
Peptide DatabaseAnonymous reference website with no named author.
Each doseMOTS-c 5–10 mg, or 15 mg when taken three times a week. SS-31 5–10 mg.
How oftenMOTS-c once a day or three times a week. SS-31 once a day.
Weekly totalMOTS-c 35–70 mg daily, or 45 mg at three times a week. SS-31 35–70 mg.
LengthNot stated.

Weekly totals are our arithmetic from each source’s own figures. Syringe units only hold for the vial and water that source assumes.

What it is promoted for

Energy, endurance and “mitochondrial health”. This is how the stack is marketed and discussed, not a finding.

What the evidence shows

We found no published human trial of the two together. MOTS-c itself has no completed human efficacy trials. SS-31 (elamipretide) is FDA-approved only for Barth syndrome, a rare genetic condition, and that evidence does not extend to healthy people.

Cautions

  • The idea that SS-31 should be taken first to “prepare” the mitochondria is a community claim with no trial behind it.
  • Both fall under the WADA rules on non-approved substances or their relatives.

Measuring each one

Each component has its own vial and its own concentration, so each is measured separately:

Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.